Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,capitalSurplus,totalLiab,totalStockholderEquity,totalAssets,commonStock,retainedEarnings,treasuryStock,cash,totalCurrentLiabilities,otherStockholderEquity,totalCurrentAssets,accountsPayable,changeToLiabilities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,effectOfExchangeRate,totalCashFromOperatingActivities,changeToNetincome,WC,language,region,quoteType,triggerable,quoteSourceName,currency,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,epsTrailingTwelveMonths,gmtOffSetMilliseconds,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,priceHint,shortName,longName,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,marketState,exchange,market,twoHundredDayAverageChangePercent,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,esgPopulated,tradeable,exchangeDataDelayedBy,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,longBusinessSummary,city,state,compensationAsOfEpochDate,country,website,maxAge,address1,industry,address2
t0,EQUR,-398851.0,34546100,84085,,-196774,,-196774,108508,0,-140652,-140652,-51941,-4182,,,,0,0,140652,0,-56122,,-196774,-196774,33805525.0,479921.0,-398851.0,81070.0,345.0,-34681693.0,476972.0,81070.0,479921.0,476972.0,81070.0,2996.0,1432,26291,59493,26291,-123295,-17919,-131667,4182,-398851.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.039 - 0.039,0.039,0.0,0.0,0,0,finmb_49977425,Other OTC,USD,3764,2833,0.022,1.2941176,0.017 - 0.103,-0.063999996,-0.62135917,0.017,0.103,1600345800,1608211800,1608298200,-0.018,-14400000,-0.012,0.035916667,0.0030833334,0.08584686,0.04454348,-0.005543478,4,E-QURE CORP,E-Qure Corp.,0.039,1630430129,0.0,0.035215,0.039,0.039,1,REGULAR,PNK,us_market,-0.124450944,1347297,-3.25,15,America/New_York,EDT,False,False,0,2.91,,,0.103,0.017,0.0359,0.0445,3.76k,2.83k,34.55M,,24.13M,30.14%,0.00%,,,,,,,,,,,0.00%,,,1:100,"Aug 03, 2014","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-749.54%,,,,,,,-612.36k,-0.0180,,81.07k,0,165.91k,,0.17,-0.01,-393.18k,-180.18k,Value,10023,Healthcare,1,"E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.",New York,NY,1609372800,United States,http://www.e-qure.com,86400,20 West 64th Street,Medical Devices,Suite 39G
t-1,EQUR,-214631.0,34546100,61499,,-172987,,-172987,107681,0,-169180,-169180,-51941,-4181,,,,0,0,169180,0,-3807,,-172987,-172987,33801343.0,418996.0,-214631.0,204365.0,345.0,-34484919.0,468600.0,204365.0,418996.0,468600.0,204365.0,,-103545,87184,145665,87184,-39502,-17919,-126686,4181,-214631.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.039 - 0.039,0.039,0.0,0.0,0,0,finmb_49977425,Other OTC,USD,3764,2833,0.022,1.2941176,0.017 - 0.103,-0.063999996,-0.62135917,0.017,0.103,1600345800,1608211800,1608298200,-0.018,-14400000,-0.012,0.035916667,0.0030833334,0.08584686,0.04454348,-0.005543478,4,E-QURE CORP,E-Qure Corp.,0.039,1630430129,0.0,0.035215,0.039,0.039,1,REGULAR,PNK,us_market,-0.124450944,1347297,-3.25,15,America/New_York,EDT,False,False,0,2.91,,,0.103,0.017,0.0359,0.0445,3.76k,2.83k,34.55M,,24.13M,30.14%,0.00%,,,,,,,,,,,0.00%,,,1:100,"Aug 03, 2014","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-749.54%,,,,,,,-612.36k,-0.0180,,81.07k,0,165.91k,,0.17,-0.01,-393.18k,-180.18k,Value,10023,Healthcare,1,"E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.",New York,NY,1609372800,United States,http://www.e-qure.com,86400,20 West 64th Street,Medical Devices,Suite 39G
t-2,EQUR,-133009.0,34546100,33972,,-85708,,-85708,99165,0,-133137,-133137,-51941,-4137,,,,0,0,133137,0,47429,,-85708,-85708,33797162.0,376876.0,-133009.0,243867.0,345.0,-34311932.0,381416.0,243867.0,376876.0,381416.0,243867.0,,42120,89440,145665,89440,49989,-17919,-39451,4137,-133009.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.039 - 0.039,0.039,0.0,0.0,0,0,finmb_49977425,Other OTC,USD,3764,2833,0.022,1.2941176,0.017 - 0.103,-0.063999996,-0.62135917,0.017,0.103,1600345800,1608211800,1608298200,-0.018,-14400000,-0.012,0.035916667,0.0030833334,0.08584686,0.04454348,-0.005543478,4,E-QURE CORP,E-Qure Corp.,0.039,1630430129,0.0,0.035215,0.039,0.039,1,REGULAR,PNK,us_market,-0.124450944,1347297,-3.25,15,America/New_York,EDT,False,False,0,2.91,,,0.103,0.017,0.0359,0.0445,3.76k,2.83k,34.55M,,24.13M,30.14%,0.00%,,,,,,,,,,,0.00%,,,1:100,"Aug 03, 2014","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-749.54%,,,,,,,-612.36k,-0.0180,,81.07k,0,165.91k,,0.17,-0.01,-393.18k,-180.18k,Value,10023,Healthcare,1,"E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.",New York,NY,1609372800,United States,http://www.e-qure.com,86400,20 West 64th Street,Medical Devices,Suite 39G
t-3,EQUR,-140878.0,34546100,59380,,-156887,,-156887,93371,0,-152751,-152751,-51941,-4136,,,,0,0,152751,0,-4136,,-156887,-156887,33793025.0,334756.0,-140878.0,193878.0,345.0,-34226224.0,291976.0,193878.0,334756.0,291976.0,193878.0,,57375,270976,145665,270976,175600,-17919,-95376,4136,-140878.0,en-US,US,EQUITY,False,Delayed Quote,USD,0.0,0.039 - 0.039,0.039,0.0,0.0,0,0,finmb_49977425,Other OTC,USD,3764,2833,0.022,1.2941176,0.017 - 0.103,-0.063999996,-0.62135917,0.017,0.103,1600345800,1608211800,1608298200,-0.018,-14400000,-0.012,0.035916667,0.0030833334,0.08584686,0.04454348,-0.005543478,4,E-QURE CORP,E-Qure Corp.,0.039,1630430129,0.0,0.035215,0.039,0.039,1,REGULAR,PNK,us_market,-0.124450944,1347297,-3.25,15,America/New_York,EDT,False,False,0,2.91,,,0.103,0.017,0.0359,0.0445,3.76k,2.83k,34.55M,,24.13M,30.14%,0.00%,,,,,,,,,,,0.00%,,,1:100,"Aug 03, 2014","Dec 30, 2020","Dec 30, 2020",0.00%,0.00%,-749.54%,,,,,,,-612.36k,-0.0180,,81.07k,0,165.91k,,0.17,-0.01,-393.18k,-180.18k,Value,10023,Healthcare,1,"E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.",New York,NY,1609372800,United States,http://www.e-qure.com,86400,20 West 64th Street,Medical Devices,Suite 39G
